The most common phase II drug-metabolizing enzymes are UDP-glucuronosyltransferases (UGTs), sulfotransferases (SULTs), N-acetyltransferases (NATs), glutathione S-transferases (GSTs), methyltransferases (thiopurine S-methyltransferases (TPMTs), catechol O-methyltransferases (COMTs)) and acyltransferases (Jancova et al., 2010
This integrative approach positions Arabidopsis not as a substitute for mammalian models, but as a complementary platform to dissect universal redox and signalling principles
Use adaptive dosing and staging matched to disease phase and compartment: for example, early ischemiareperfusion may benefit from acute, time-boxed control of mitochondrial bursts and labile iron to limit Fenton chemistry, while chronic vascular or organ remodeling calls for rebalancing NOX activity and ER stress together with lifestyle re-entrainment (exercise, nutrition, sleep, exposure control) to reset redox tone without erasing physiological H 2 O 2 signalling (Poznyak et al
Many peptides lack stability and must be administered subcutaneously